Effectiveness of Radial Extracorporeal Shock Wave Therapy and Supervised Exercises in Lateral Epicondylitis

NCT ID: NCT03834090

Last Updated: 2019-02-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

41 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-02-20

Study Completion Date

2016-01-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

No consensus has yet been built on the treatment of lateral epicondylitis (LE) due to the lack of evidence. Although conflicting results are present, radial extracorporeal shock wave therapy (rESWT) has increasingly been used in the treatment of tendinopathy

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

ESWT and exercise have beneficial effects on the management of tendinopathies owing to their various mechanisms that showed therapeutic efficacy. Owing to its positive outcomes, extracorporeal shock wave therapy (ESWT) has recently been used in the treatment of musculoskeletal system diseases such as plantar fasciitis, Achilles tendinopathy, calcific rotator cuff tendinopathies, and patellar tendinopathy

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lateral Epicondylitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

rESWT

the group receiving rESWT

Group Type EXPERIMENTAL

rESWT

Intervention Type DEVICE

rESWT was administered once per week for 3 weeks using a ShockMaster 500 device with 1.8 bar pneumatic pressure, 10 Hz frequency, with 2000 pulses.

supervised exercises

the group receiving supervised exercises

Group Type ACTIVE_COMPARATOR

Supervised exercises

Intervention Type OTHER

A program including post-isometric relaxation, and progressive resistance exercise (eccentric wrist extension) on the wrist extensors

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

rESWT

rESWT was administered once per week for 3 weeks using a ShockMaster 500 device with 1.8 bar pneumatic pressure, 10 Hz frequency, with 2000 pulses.

Intervention Type DEVICE

Supervised exercises

A program including post-isometric relaxation, and progressive resistance exercise (eccentric wrist extension) on the wrist extensors

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The diagnosis of LE was made in the clinical examination, and the diagnosis was confirmed with the Southampton Diagnostic Criteria of "the presence of epicondyle pain, and epicondyle pain and tenderness on resisted extension of the wrist.
* Patients with symptoms lasting longer than 3 months
* with average pain in the previous week detected as 3 or above on a 10-cm visual analogue scale (VAS)
* who were aged over 18 years

Exclusion Criteria

* pain in the proximal part of the affected extremity (e.g. shoulder pain, neck pain)
* abnormal neurogenic symptoms (e.g. radicular pain, numbness) on the affected extremity
* presence of posterior interosseous nerve entrapment
* congenital or acquired upper extremity deformities that might affect grip strength
* systemic musculoskeletal system or neurologic disorders
* systemic rheumatologic disease or systemic infection
* presence of malignancy, coagulation disorders, and anticoagulant use
* inserted cardiac pacemaker
* history of surgical treatment on the elbow of the affected extremity
* pregnancy.
* patients who were administered other treatments such as physical therapy or steroid injections in the last 3 months
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Istanbul University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

MUSTAFA CORUM

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2015/369

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.